← back to search

Lin Shen

Ministry of Education ·
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research focused on Oncology and Cetuximab, with related work in Ramucirumab, Colorectal cancer, Trastuzumab. Notable publications include 'Encorafenib, Cetuximab, and mFOLFOX6 in BRAF -Mutated Colorectal Cancer', 'Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer', and 'Safety and efficacy of QLS31905 in patients with advanced solid tumors: Updated data from phase 1 study'.
h-index
citations
173
works
4
NIH funding
primary concept
email

Recent publications

Encorafenib, Cetuximab, and mFOLFOX6 in <i>BRAF</i> -Mutated Colorectal Cancer
New England Journal of Medicine 2025cited by 98position: middledoi
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
New England Journal of Medicine 2025cited by 72position: middledoi
Safety and efficacy of QLS31905 in patients with advanced solid tumors: Updated data from phase 1 study.
Journal of Clinical Oncology 2025cited by 3position: lastdoi
Long‐term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial
Cancer 2025cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Josep Tabernero · Medical Research Network2 papers (2025–2025)Sara Lonardi · Istituto Oncologico Veneto2 papers (2025–2025)Eric Van Cutsem · KU Leuven2 papers (2025–2025) · 1 papers (2025–2025)Xiaosong Zhang · Nantong University1 papers (2025–2025)Jing Lv · Xinjiang Medical University1 papers (2025–2025)Shujun Yang · Ningbo University1 papers (2025–2025)Christina Wu · University of California San Diego1 papers (2025–2025)Yuping Sun · Shandong University1 papers (2025–2025)Jinlu Shan · Shandong First Medical University1 papers (2025–2025)Elena Élez · Hôpital Saint-Antoine1 papers (2025–2025)Junye Wang · Linzhou Cancer Hospital1 papers (2025–2025)Takahiro Kamio · Daiichi Sankyo (United States)1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2025–2025)Yanqiao Zhang · Harbin Medical University1 papers (2025–2025)Jifang Gong · Peking University1 papers (2025–2025)Fabricio Souza · Daiichi Sankyo (United States)1 papers (2025–2025)Robert J Laliberte · Pfizer (United States)1 papers (2025–2025)Yu Cao · Kunming University of Science and Technology1 papers (2025–2025)